Predicting Progress in Protein Aggregation
January 27, 2014 - by: Cynthia Challener, PhD. Biopharm International
Techniques to enable the design and formulation of stable, protein-based therapeutics.
Determining Criticality, Part Two: DoE and Data-Driven Criticalit
January 27, 2014 - by: Mark Mitchell, Biopharm International
A practical roadmap in three parts that applies scientific knowledge, risk analysis, experimental data, and process monitoring throughout the three phases of the pro
…
Regulation of Biosimilars: A Matter of Variability, Similarity, a
January 19, 2014 - By: Sean Milmo BioPharm International
As the European Union takes a closer look at its biosimilars guidelines, some key issues are proving difficult to resolve.
Best Practices in Adopting Single-Use Systems
January 19, 2014 - By: John Schmitz BioPharm International
Drugs, At What Cost?
The underlying question for any
January 19, 2014 - By: Rita Peters BioPharm International
Generics, market dynamics, and global demand are changing drug spending patterns.
2014 Manufacturing Trends and Outlook
January 19, 2014 - By: Rita Peters BioPharm International
Single-use systems and other technologies drive process efficiencies, but there is room for improvement.
Determining Criticality-Process Parameters and Quality Attributes
January 11, 2014 - By: Mark Mitchell BioPharm International
A practical roadmap in three parts that applies scientific knowledge, risk analysis, experimental data, and process monitoring throughout the three phase
…
Implementing QbD in Sterile Manufacturing
December 31, 2013 - By: Susan Haigney, BioPharm International
To gain perspective on the implementation of quality by design (QbD) in sterile manufacturing, BioPharm International spoke with Wolfgang Weikmann, vice-
…
Biotechnology Innovation and Growth in Israel
December 31, 2013 - By: Jill E. Sackman, Michael Kuchenreuther BioPharm International
Israel's diverse population, high-quality healthcare system, and resilience to global financial stress make it a strong partner for R&D, clinical research, and
…
Climate Change in Outsourcing
December 31, 2013 - By: Jim Miller BioPharm International
As 2013 draws to a close, the bio/pharmaceutical industry continues to be reshaped by changes in the business climate. Financial, political, and scientific deve
…